Development of program therapy for patients with acute myeloid leukemia under the age of 60 years, based on the principles of differentiated effects

Development of program therapy for patients with acute myeloid leukemia under the age of 60 years, based on the principles of differentiated effects

Aim. To analyze the results of treatment in patients with acute myeloid leukemia (AML) within protocols AML-17 and modified AML-17 (mOML-17) as part of two consecutive pilot studies in order to develop the best treatment strategy for AML patients aged below 60 years. Materials and methods. The st...

Full description

Bibliographic Details
Main Authors: Elena N. Parovichnikova, Irina A. Lukianova, Vera V. Troitskaya, Mikhail Yu. Drokov, Larisa A. Kuzmina, Andrei N. Sokolov, Alina V. Kokhno, Zalina T. Fidarova, Irina V. Galtseva, Yuliya O. Davydova, Anastasiia I. Kashlakova, Elena O. Gribanova, Eugene E. Zvonkov, Elena P. Sysoeva, Valentina N. Dvirnyk, Tatiana N. Obukhova, Andrei B. Sudarikov, Yuliya V. Sidorova, Sergei M. Kulikov, Yuliia A. Chabaeva, Valerii G. Savchenko
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2021-07-01
Series:Терапевтический архив
Subjects:
acute myeloid leukemia
minimal residual disease
risk group
transplantation of allogeneic hematopoietic stem cells
Online Access:https://ter-arkhiv.ru/0040-3660/article/viewFile/76304/56900

Internet

https://ter-arkhiv.ru/0040-3660/article/viewFile/76304/56900

Similar Items